Evaluation of heparin binding protein as a prognostic biomarker for diagnosis of sepsis at tertiary care hospital, North India

Ashish K. Gupta; Rajendra K. Verma; Richa Giri; Ajesh C. Gupta

doi:10.18203/2349-3933.ijam20243818

Authors

Ashish K. Gupta Department of Medicine, G.S.V.M. Medical College, Kanpur, Uttar Pradesh, India
Rajendra K. Verma Department of Medicine, G.S.V.M. Medical College, Kanpur, Uttar Pradesh, India
Richa Giri Department of Medicine, G.S.V.M. Medical College, Kanpur, Uttar Pradesh, India
Ajesh C. Gupta Department of Medicine, G.S.V.M. Medical College, Kanpur, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20243818

Keywords:

Sepsis, HBP, Biomarker, Organ dysfunction, Infection status, Prognosis

Abstract

Background: Sepsis is a critical condition characterized by systemic inflammation in response to infection, often leading to organ dysfunction and mortality. Heparin-binding protein (HBP) has emerged as a potential biomarker for early sepsis detection due to its rapid release and association with inflammatory processes. This study aimed to evaluate HBP as a prognostic biomarker for diagnosing sepsis, assessing its correlation with demographic characteristics, infection status, organ dysfunction, and biochemical parameters.

Methods: A prospective analytical study was conducted at G.S.V.M. Medical College, Kanpur, from December 2022 to May 2024, involving 113 patients over 18 years old suspected of sepsis. Clinical data, including demographics, infection status, organ dysfunction, and HBP levels, were collected and analyzed using statistical methods.

Results: The study cohort exhibited a mean age of 53.2±19.3 years, with balanced gender representation (49.6% male, 50.4% female) and varied infection statuses (47.8% confirmed infections, 17.7% probable, and 9.7% viral). Organ dysfunction prevalence increased from 30.1% on admission to 43.4% within 72 hours. HBP levels decreased significantly from baseline (11.28 ng/ml) to 72 hours (5.68 ng/ml), showing potential for monitoring disease progression. Significant differences in baseline HBP levels among patient groups were observed (p≤0.001).

Conclusions: The study concludes that HBP is a promising biomarker for distinguishing infection statuses, aiding in sepsis diagnosis, with significant differences observed in HBP levels across diagnostic categories, enhancing early detection and targeted treatment.

Metrics

Metrics Loading ...

References

Sepsis Alliance. Sepsis Overview. 2024. Available at: https://www.sepsis.org/. Accessed on 24 September 2024.

Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, et al; Milwaukee Initiative in Critical Care Outcomes Research (MICCOR) Group of Investigators. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest. 2011;140(5):1223-31.

Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al; International Forum of Acute Care Trialists. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med. 2016;193(3):259-72.

Schneider D, Roberts D, Wood KE, Light B, Parrillo JE, Suppes R, et al. The key factor influencing survival in human septic shock is the length of hypotension prior to the start of effective antimicrobial treatment. Acute Care Med. 2006,34(6):1589-96.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.

van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407-20.

Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al; Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):775-87.

Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018;44(6):925-8.

Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.

Fisher J, Linder A. Heparin-binding protein: a key player in the pathophysiology of organ dysfunction in sepsis. J Intern Med. 2017;281(6):562-74.

Kahn F, Tverring J, Mellhammar L, Wetterberg N, Bläckberg A, Studahl E, et al. Heparin-binding protein as a prognostic biomarker of sepsis and disease severity at the emergency department. Shock. 2019;52(6):e135-45.

Zuo L, Li X, Wang L, Yuan H, Liao Z, Zhou S, et al. Heparin-binding protein as a biomarker for the diagnosis of sepsis in the intensive care unit: a retrospective cross-sectional study in China. BMJ Open. 2024;14(6):e078687.